4th Mitochondrial Dysfunction Drug Development Summit

R&D
4th Mitochondrial Dysfunction Drug Development Summit banner image

The 4th Mitochondrial Dysfunction Drug Development Summit returns in 2024, to unite pharma, biotech and academia on cutting-edge research and pipeline updates expanding the therapeutic opportunities for mitochondrial targeting approaches. Join us this November to meet 60+ C-Level, Biologist, Preclinical, Translational and Innovation-Scouting Leaders who are transforming our understanding of mechanisms rooted in disease pathogenesis involving mitochondria, to de-risk clinical development of novel, patient centered therapeutics through the discovery and validation of biomarkers for defined endpoints.

Pre-competitively combine your expertise with the likes of Astellas Pharma, MitoChem Therapeutics, Mitotherapeutix and Pretzel Therapeutics to unlock the potential of mitochondrial-targeting technologies, benefit from novel clinical intelligence and maximize patient engagement for a promising investor landscape. Uncover mitochondrial dysfunction in diverse patient populations and develop higher efficacy targeting tactics for primary mitochondrial diseases as well as neurology, immunology, oncology, diabetes and aging-related indications.

Why attend:

  • Expand on your understanding of the mitochondrial genome to model mtDNA mutations and uncover disease mechanisms with University of Cambridge
  • Unpick clinical data on a unique mitochondrial uncoupler to witness its efficacy on the treatment of ALS, MS, and Alzheimer’s disease with Mitochon Pharmaceuticals
  • Explore how mitochondrial transplant is utilized to enhance cellular function and demonstrate age-reversal effects in the immune system of elderly patients with Mitrix Bio
  • Unlock novel pathways for targeting mitochondria to expedite the discovery and validation of biomarkers for Parkinson’s disease with Anavex Life Sciences
  • Establish strategies for collecting, assessing, and leveraging registry data to navigate patient-centric approaches for regulatory success with Cure Mito Foundation

Download the agenda here: https://ter.li/k1vs14

Don’t miss out on this premiere event - register now and enjoy up to 20% off if you bring your colleagues! Register online here: https://ter.li/ktz5yq

Dates: November 19-21, 2024

Location: Hilton Boston Back Bay, 40 Dalton St, Boston, MA 02115, United States

Event guide: https://ter.li/k1vs14

Image
4th Mitochondrial Dysfunction Drug Development Summit logo